SCHEMBL6987084

SCHEMBL6987084

Nc1nccnc1Sc1nnc(SCc2ccccc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
HPGD P15428 2/20 0.50
FFAR1 O14842 1/20 0.49
MAPK1 P28482 1/20 0.49
ALDH1A1 P00352 4/20 0.48
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 5/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CA1 P00915 1/20 0.45
HSD17B10 Q99714 1/20 0.44
GAA P10253 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TERT O14746 1/20 0.41
KDM4E B2RXH2 3/20 0.39
RECQL P46063 1/20 0.39
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24700466 0.81 LMNA (0.66) LMNAHPGDFFAR1MAPK1ALDH1A1
SCHEMBL1720006 0.81 LMNA (0.47) LMNAHPGDFFAR1MAPK1ALDH1A1
SCHEMBL3263155 0.79 LMNA (0.72) LMNAHPGDFFAR1MAPK1ALDH1A1
SCHEMBL6994384 0.79 ALDH1A1 (0.50) LMNAHPGDMAPK1ALDH1A1MAPT
SCHEMBL6992257 0.76 MAPT (0.42) LMNAHPGDMAPK1ALDH1A1MAPT
SCHEMBL6989319 0.75 ALDH1A1 (0.35) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL3906094 0.75 MAPK1 (0.62) LMNAHPGDFFAR1MAPK1ALDH1A1
SCHEMBL23137230 0.74 LMNA (0.66) LMNAHPGDFFAR1MAPK1ALDH1A1
SCHEMBL6990452 0.74 ALDH1A1 (0.49) LMNAHPGDMAPK1ALDH1A1MAPT
SCHEMBL23137231 0.71 LMNA (0.62) LMNAHPGDFFAR1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2452683-A2 Methods for treating atherosclerosis Amgen Inc. (US) 2012-05-16 EP disclosed
EP-2037928-B1 METHODS FOR TREATING ATHEROSCLEROSIS AMGEN INC (US) 2012-01-11 EP disclosed
WO-2008002591-A2 METHODS FOR TREATING ATHEROSCLEROSIS AMGEN INC (US) 2008-01-03 WO disclosed